Probiotics improves sepsis-induced acute lung injury in association with intestinal microbiota and pulmonary concentrations of Th17 and Treg

IF 3.6 Q2 BIOTECHNOLOGY & APPLIED MICROBIOLOGY
{"title":"Probiotics improves sepsis-induced acute lung injury in association with intestinal microbiota and pulmonary concentrations of Th17 and Treg","authors":"","doi":"10.1016/j.crbiot.2024.100238","DOIUrl":null,"url":null,"abstract":"<div><p>This study aims to assess the immune status of septic acute lung injury (ALI) at various stages and to investigate whether probiotics can mitigate ALI in septic rats. Rats were randomly assigned to sham, caecal ligation and puncture (CLP), and probiotic treatment after CLP (CLP+PT) group. Intestinal contents, bronchoalveolar lavage fluid (BALF), and lung tissue were collected from rats at 6, 24 and 48 h after CLP. Results showed that Th17 level at 24 h in BALF is significantly higher than that at 6 and 48 h. The Treg level increased after CLP and reached its highest point at 48 h. Pathological damage in the alveolar interstitium intensified over time. At 24 h, Th17 percentage of BALF significantly increased in the CLP group while it significantly decreased in the CLP+PT group, and the Treg percentage of BALF at 48 h showed the same alteration trend. Alveolar interstitial pathological damage in the CLP+PT group was reduced at all time points compared to the CLP group. The abundance of Firmicutes was higher and Bacteroidetes lower in the sepsis group compared to the sham group. However, the abundance of these bacteria was similar between the probiotic and pseudo-probiotic groups. Actinomycetes levels differed significantly among the three groups, with the probiotic group exhibiting significantly higher levels. Bifidobacteria levels were significantly higher in the probiotic group compared to the sepsis group. Phenotype prediction indicated a higher proportion of biofilm formation in the probiotic group compared to the sepsis group. In conclusions, significant alterations in Th17 and Treg levels in BALF of septic rats suggest a shift in the distribution of important T lymphocytes in the lungs during sepsis. Probiotics modulated the gut microbiota of septic rats, downregulated the highest value of Th17 and Treg percentage in BAFL, resulting in mitigated lung injury in rats.</p></div>","PeriodicalId":52676,"journal":{"name":"Current Research in Biotechnology","volume":null,"pages":null},"PeriodicalIF":3.6000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2590262824000649/pdfft?md5=b22f5c8a77972b0f8faeaaa5a8a5d20a&pid=1-s2.0-S2590262824000649-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Research in Biotechnology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2590262824000649","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

This study aims to assess the immune status of septic acute lung injury (ALI) at various stages and to investigate whether probiotics can mitigate ALI in septic rats. Rats were randomly assigned to sham, caecal ligation and puncture (CLP), and probiotic treatment after CLP (CLP+PT) group. Intestinal contents, bronchoalveolar lavage fluid (BALF), and lung tissue were collected from rats at 6, 24 and 48 h after CLP. Results showed that Th17 level at 24 h in BALF is significantly higher than that at 6 and 48 h. The Treg level increased after CLP and reached its highest point at 48 h. Pathological damage in the alveolar interstitium intensified over time. At 24 h, Th17 percentage of BALF significantly increased in the CLP group while it significantly decreased in the CLP+PT group, and the Treg percentage of BALF at 48 h showed the same alteration trend. Alveolar interstitial pathological damage in the CLP+PT group was reduced at all time points compared to the CLP group. The abundance of Firmicutes was higher and Bacteroidetes lower in the sepsis group compared to the sham group. However, the abundance of these bacteria was similar between the probiotic and pseudo-probiotic groups. Actinomycetes levels differed significantly among the three groups, with the probiotic group exhibiting significantly higher levels. Bifidobacteria levels were significantly higher in the probiotic group compared to the sepsis group. Phenotype prediction indicated a higher proportion of biofilm formation in the probiotic group compared to the sepsis group. In conclusions, significant alterations in Th17 and Treg levels in BALF of septic rats suggest a shift in the distribution of important T lymphocytes in the lungs during sepsis. Probiotics modulated the gut microbiota of septic rats, downregulated the highest value of Th17 and Treg percentage in BAFL, resulting in mitigated lung injury in rats.

Abstract Image

益生菌能改善脓毒症诱发的急性肺损伤,这与肠道微生物群和肺中 Th17 和 Treg 的浓度有关
本研究旨在评估脓毒症急性肺损伤(ALI)不同阶段的免疫状态,并探讨益生菌是否能缓解脓毒症大鼠的ALI。大鼠被随机分配到假组、盲肠结扎和穿刺(CLP)组以及盲肠结扎和穿刺后益生菌治疗(CLP+PT)组。在CLP后6、24和48小时收集大鼠的肠内容物、支气管肺泡灌洗液(BALF)和肺组织。结果显示,大鼠 24 h 后 BALF 中 Th17 的水平明显高于 6 h 和 48 h。24 h时,CLP组BALF中的Th17百分比显著增加,而CLP+PT组则显著减少,48 h时BALF中的Treg百分比也呈现相同的变化趋势。与CLP组相比,CLP+PT组肺泡间质病理损伤在所有时间点均有所减轻。与假手术组相比,脓毒症组的固有菌丰度较高,类杆菌丰度较低。不过,益生菌组和假益生菌组的这些细菌的丰度相似。放线菌的含量在三组之间存在显著差异,益生菌组的含量明显更高。益生菌组的双歧杆菌含量明显高于败血症组。表型预测显示,与败血症组相比,益生菌组形成生物膜的比例更高。总之,脓毒症大鼠BALF中Th17和Treg水平的显著变化表明,脓毒症期间肺部重要T淋巴细胞的分布发生了变化。益生菌调节了脓毒症大鼠的肠道微生物群,降低了Th17和Treg在BAFL中的最高值,从而减轻了大鼠的肺损伤。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Current Research in Biotechnology
Current Research in Biotechnology Biochemistry, Genetics and Molecular Biology-Biotechnology
CiteScore
6.70
自引率
3.60%
发文量
50
审稿时长
38 days
期刊介绍: Current Research in Biotechnology (CRBIOT) is a new primary research, gold open access journal from Elsevier. CRBIOT publishes original papers, reviews, and short communications (including viewpoints and perspectives) resulting from research in biotechnology and biotech-associated disciplines. Current Research in Biotechnology is a peer-reviewed gold open access (OA) journal and upon acceptance all articles are permanently and freely available. It is a companion to the highly regarded review journal Current Opinion in Biotechnology (2018 CiteScore 8.450) and is part of the Current Opinion and Research (CO+RE) suite of journals. All CO+RE journals leverage the Current Opinion legacy-of editorial excellence, high-impact, and global reach-to ensure they are a widely read resource that is integral to scientists' workflow.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信